218 related articles for article (PubMed ID: 8427659)
21. Commentary on Shigetomi and Kuchel's work on DOPA decarboxylation.
Zimlichman R
Am J Hypertens; 1993 Jan; 6(1):89-90. PubMed ID: 8427668
[No Abstract] [Full Text] [Related]
22. Effects of water immersion on sympathoadrenal and dopa-dopamine systems in humans.
Grossman E; Goldstein DS; Hoffman A; Wacks IR; Epstein M
Am J Physiol; 1992 Jun; 262(6 Pt 2):R993-9. PubMed ID: 1535759
[TBL] [Abstract][Full Text] [Related]
23. Levodopa, carbidopa, and pyridoxine in Parkinson disease. Metabolic interactions.
Mars H
Arch Neurol; 1974 Jun; 30(6):444-7. PubMed ID: 4827061
[No Abstract] [Full Text] [Related]
24. gamma-L-glutamyl-L-DOPA inhibits Na(+)-phosphate cotransport across renal brush border membranes and increases renal excretion of phosphate.
de Toledo FG; Thompson MA; Bolliger C; Tyce GM; Dousa TP
Kidney Int; 1999 May; 55(5):1832-42. PubMed ID: 10231445
[TBL] [Abstract][Full Text] [Related]
25. A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine.
Brown MJ; Dollery CT
Br J Clin Pharmacol; 1981 Jan; 11(1):79-83. PubMed ID: 6783056
[TBL] [Abstract][Full Text] [Related]
26. The renal dopaminergic system, neurohumoral activation, and sodium handling in heart failure.
Ferreira A; Bettencourt P; Pimenta J; Friões F; Pestana M; Soares-da-Silva P; Cerqueira-Gomes M
Am Heart J; 2002 Mar; 143(3):391-7. PubMed ID: 11868042
[TBL] [Abstract][Full Text] [Related]
27. Differential catecholamine responses to protein intake in healthy and hypertensive subjects.
Kuchel O
Am J Physiol; 1998 Oct; 275(4):R1164-73. PubMed ID: 9756547
[TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
Andersen AD; Blaabjerg M; Binzer M; Kamal A; Thagesen H; Kjaer TW; Stenager E; Gramsbergen JBP
J Neurochem; 2017 May; 141(4):614-625. PubMed ID: 28244186
[TBL] [Abstract][Full Text] [Related]
29. The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats.
Rose S; Jenner P; Marsden CD
Mov Disord; 1988; 3(2):117-25. PubMed ID: 3221899
[TBL] [Abstract][Full Text] [Related]
30. Effects of thyroid hormone on the renal dopaminergic system.
Del Compare JA; Aguirre JA; Ibarra FR; Barontini M; Armando I
Endocrine; 2001 Aug; 15(3):297-303. PubMed ID: 11762703
[TBL] [Abstract][Full Text] [Related]
31. Heart failure, aging, and renal synthesis of dopamine.
Ferreira A; Bettencourt P; Pestana M; Correia F; Serrão P; Martins L; Cerqueira-Gomes M; Soares-Da-Silva P
Am J Kidney Dis; 2001 Sep; 38(3):502-9. PubMed ID: 11532681
[TBL] [Abstract][Full Text] [Related]
32. Deficiency of renal dopaminergic-dependent natriuretic response to acute sodium load in black salt-sensitive subjects in contrast to salt-resistant subjects.
Damasceno A; Santos A; Serrão P; Caupers P; Soares-da-Silva P; Polónia J
J Hypertens; 1999 Dec; 17(12 Pt 2):1995-2001. PubMed ID: 10703901
[TBL] [Abstract][Full Text] [Related]
33. [Dopamine and hypertension].
Sigetomi S; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1993 Oct; 69(9):953-62. PubMed ID: 8262273
[TBL] [Abstract][Full Text] [Related]
34. Modulation of natriuresis and renal dopamine excretion by sympathetic activity and the renin-angiotensin-aldosterone system.
Barendregt JN; van Nispen tot Pannerden LA; Chang PC
J Hum Hypertens; 1994 Oct; 8(10):747-54. PubMed ID: 7837211
[TBL] [Abstract][Full Text] [Related]
35. CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.
Eldrup E; Mogensen P; Jacobsen J; Pakkenberg H; Christensen NJ
Acta Neurol Scand; 1995 Aug; 92(2):116-21. PubMed ID: 7484057
[TBL] [Abstract][Full Text] [Related]
36. Dopamine deficiency--its potential contribution to chronic renal failure complicating hypertension.
Kuchel O; Shigetomi S
Hypertens Res; 1995 Jun; 18 Suppl 1():S183-5. PubMed ID: 8529056
[TBL] [Abstract][Full Text] [Related]
37. Involvement of tubular sodium in the formation of dopamine in the human renal cortex.
Soares-da-Silva P; Pestana M; Fernandes MH
J Am Soc Nephrol; 1993 Mar; 3(9):1591-9. PubMed ID: 8507815
[TBL] [Abstract][Full Text] [Related]
38. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
Huang L; Deng M; Zhang S; Fang Y; Li L
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
[TBL] [Abstract][Full Text] [Related]
39. Dopa, catecholamines and their metabolites in essential hypertension.
Januszewicz W; Wocial B
Clin Sci Mol Med Suppl; 1975 Jun; 2():295s-298s. PubMed ID: 1077780
[TBL] [Abstract][Full Text] [Related]
40. The adrenal glands as suppliers of plasma L-Dopa and sources of urinary dopamine.
Hansell P; Källskog O; Wolgast M
Kidney Blood Press Res; 1996; 19(2):109-14. PubMed ID: 8871890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
